國立虎尾科技大學 |

Antibody Therapy = Substitution – Immunomodulation – Monoclonal Immunotherapy /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Antibody Therapy/ edited by Paul Imbach.
Reminder of title:	Substitution – Immunomodulation – Monoclonal Immunotherapy /
other author:	Imbach, Paul.
Description:	XIV, 363 p. 47 illus., 32 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Hematology. -
Online resource:	https://doi.org/10.1007/978-3-319-68038-5
ISBN:	9783319680385

Antibody Therapy = Substitution – Immunomodulation – Monoclonal Immunotherapy /
Antibody TherapySubstitution – Immunomodulation – Monoclonal Immunotherapy /[electronic resource] :edited by Paul Imbach. - 1st ed. 2018. - XIV, 363 p. 47 illus., 32 illus. in color.online resource.

The Clinical Translation of Intravenous Immunoglobulin from Substitution to Immunomodulation -- From ImmuneSubstitution to Immunomodulation -- Manual of Primary and Secondary Immunodeficiencies -- Manual of Intravenous and Subcutanous IgG Indications in Autoimmune diseases -- Anti-D IgG Concentrate; a Type of IVIg -- Mechanisms ofAction/Immunomodulation by IgG Concentrate -- Immunomodulatory Drugs and Monoclonal Antibodies -- Use of Intravenous Immunoglobulin in Neurology -- Use of Intravenous Immunoglobulin in Dermatology -- Historical Aspects ofPoliclonal IgG Preparations -- Basics of Immunoglobulins as Effector Molecules and Drugs -- Essentials of the Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentrates -- Current IgG Products and FuturePerspectives -- Immune Thrombocytopenia: Terminology, Immunomodulation and Platelet Stimulation, ClinicalGuidelines and Management -- Health-Related Quality of life in patients with Immune Thrombocytopenia -- ITP in Childhood: Predictors of Disease Duration -- Immune Functions of Platelets -- Thrombopoietin Receptor Agonists: Characteristics, Adverse Effects and Indications -- Registries in Immune Thrombocytopenia: The History of the Intercontinental Cooperative ITP Study Group -- Monoclonal Antibodies as Immunomodulators and Anti-CancerAgents : Development, Methods, Mechanisms of Actions, Adverse Effects, List of Registered and phase II/IIIMonoclonal Antibodies Targeted to -- Monoclonal Anti-CD20 (B-Cell) Antibody and Autoimmune Diseases.

This practical manual, written by well-known experts, reviews current indications for the use of IgG concentrates and some other modern immunomodulators and provides fundamental information on present-day immunomodulation in patients (and mice). The book opens by tracing the transition from IgG substitution to IgG immunomodulation and providing expert updates on immunomodulatory indications in autoimmune and inflammatory disorders, including hematologic, neurologic, dermatologic, and other diseases. Basic aspects of IgG concentrates, including methods of production, safety, currently available products, and mechanisms of action, are then discussed. An entire chapter is devoted to the different aspects of immunomodulatory IgG treatment in the bleeding disorder immune thrombocytopenia (ITP). Finally, the transition from polyclonal to monoclonal antibody (mAb) treatment is addressed in detail, covering mAb development, methods, mechanisms of action, adverse effects, and more. Particular attention is paid to the example of anti-CD20 (B-cell) antibody.

ISBN: 9783319680385

Standard No.: 10.1007/978-3-319-68038-5doiSubjects--Topical Terms:

645254
Hematology.

LC Class. No.: RB45

Dewey Class. No.: 616.15

Antibody Therapy = Substitution – Immunomodulation – Monoclonal Immunotherapy /
LDR:03942nam a22003975i 4500 001 992654
003 DE-He213
005 20200705153721.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319680385 $9 978-3-319-68038-5
024 7 $a 10.1007/978-3-319-68038-5 $2 doi
035 $a 978-3-319-68038-5
050 4 $a RB45
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJF $2 thema
082 0 4 $a 616.15 $2 23
245 1 0 $a Antibody Therapy $h [electronic resource] : $b Substitution – Immunomodulation – Monoclonal Immunotherapy / $c edited by Paul Imbach.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a XIV, 363 p. 47 illus., 32 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a The Clinical Translation of Intravenous Immunoglobulin from Substitution to Immunomodulation -- From ImmuneSubstitution to Immunomodulation -- Manual of Primary and Secondary Immunodeficiencies -- Manual of Intravenous and Subcutanous IgG Indications in Autoimmune diseases -- Anti-D IgG Concentrate; a Type of IVIg -- Mechanisms ofAction/Immunomodulation by IgG Concentrate -- Immunomodulatory Drugs and Monoclonal Antibodies -- Use of Intravenous Immunoglobulin in Neurology -- Use of Intravenous Immunoglobulin in Dermatology -- Historical Aspects ofPoliclonal IgG Preparations -- Basics of Immunoglobulins as Effector Molecules and Drugs -- Essentials of the Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentrates -- Current IgG Products and FuturePerspectives -- Immune Thrombocytopenia: Terminology, Immunomodulation and Platelet Stimulation, ClinicalGuidelines and Management -- Health-Related Quality of life in patients with Immune Thrombocytopenia -- ITP in Childhood: Predictors of Disease Duration -- Immune Functions of Platelets -- Thrombopoietin Receptor Agonists: Characteristics, Adverse Effects and Indications -- Registries in Immune Thrombocytopenia: The History of the Intercontinental Cooperative ITP Study Group -- Monoclonal Antibodies as Immunomodulators and Anti-CancerAgents : Development, Methods, Mechanisms of Actions, Adverse Effects, List of Registered and phase II/IIIMonoclonal Antibodies Targeted to -- Monoclonal Anti-CD20 (B-Cell) Antibody and Autoimmune Diseases.
520 $a This practical manual, written by well-known experts, reviews current indications for the use of IgG concentrates and some other modern immunomodulators and provides fundamental information on present-day immunomodulation in patients (and mice). The book opens by tracing the transition from IgG substitution to IgG immunomodulation and providing expert updates on immunomodulatory indications in autoimmune and inflammatory disorders, including hematologic, neurologic, dermatologic, and other diseases. Basic aspects of IgG concentrates, including methods of production, safety, currently available products, and mechanisms of action, are then discussed. An entire chapter is devoted to the different aspects of immunomodulatory IgG treatment in the bleeding disorder immune thrombocytopenia (ITP). Finally, the transition from polyclonal to monoclonal antibody (mAb) treatment is addressed in detail, covering mAb development, methods, mechanisms of action, adverse effects, and more. Particular attention is paid to the example of anti-CD20 (B-cell) antibody.
650 0 $a Hematology. $3 645254
650 0 $a Immunology. $3 592892
650 0 $a Oncology . $3 1253469
650 2 4 $a Oncology. $3 593951
700 1 $a Imbach, Paul. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 786776
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319680378
776 0 8 $i Printed edition: $z 9783319680392
776 0 8 $i Printed edition: $z 9783030098193
856 4 0 $u https://doi.org/10.1007/978-3-319-68038-5
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)